Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Willis

Showing results (451-460 of 470) with videos related to

Pageof 47
Sort By:
Immunity|September 30, 2022
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized miceEleonora Melzi, Jordan R Willis, Krystal M Ma, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective studyG R de Jesús, S Sciascia, D Andrade, et al.
NPJ Biofilms and Microbiomes|February 2, 2023
Glycoside hydrolase processing of the Pel polysaccharide alters biofilm biomechanics and Pseudomonas aeruginosa virulenceErum Razvi, Gregory B Whitfield, Courtney Reichhardt, et al.
Science Immunology|May 16, 2024
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse modelsXuesong Wang, Christopher A Cottrell, Xiaozhen Hu, et al.
Immunity|September 30, 2022
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursorsJordan R Willis, Zachary T Berndsen, Krystal M Ma, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Water Research|October 3, 2022
Interlaboratory performance and quantitative PCR data acceptance metrics for NIST SRM® 2917Mano Sivaganesan, Jessica R Willis, Mohammad Karim, et al.
Journal of Veterinary Internal Medicine|September 10, 2013
Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.
Journal of Veterinary Internal Medicine|July 22, 2008
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Pageof 47

Showing results (451-460 of 470) with videos related to

Sort By:
Pageof 47
Immunity|September 30, 2022
Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized miceEleonora Melzi, Jordan R Willis, Krystal M Ma, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective studyG R de Jesús, S Sciascia, D Andrade, et al.
NPJ Biofilms and Microbiomes|February 2, 2023
Glycoside hydrolase processing of the Pel polysaccharide alters biofilm biomechanics and Pseudomonas aeruginosa virulenceErum Razvi, Gregory B Whitfield, Courtney Reichhardt, et al.
Science Immunology|May 16, 2024
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse modelsXuesong Wang, Christopher A Cottrell, Xiaozhen Hu, et al.
Immunity|September 30, 2022
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursorsJordan R Willis, Zachary T Berndsen, Krystal M Ma, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Water Research|October 3, 2022
Interlaboratory performance and quantitative PCR data acceptance metrics for NIST SRM® 2917Mano Sivaganesan, Jessica R Willis, Mohammad Karim, et al.
Journal of Veterinary Internal Medicine|September 10, 2013
Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.
Journal of Veterinary Internal Medicine|July 22, 2008
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 1, 2024
Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's diseaseMichelle M Mielke, Matthew Anderson, J Wesson Ashford, et al.
Pageof 47